| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1666* | 2020 |
| The landscape of genomic alterations across childhood cancers SN Gröbner, BC Worst, J Weischenfeldt, I Buchhalter, K Kleinheinz, ... Nature 555 (7696), 321-327, 2018 | 1275 | 2018 |
| Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone S Behjati, PS Tarpey, N Presneau, S Scheipl, N Pillay, P Van Loo, ... Nature genetics 45 (12), 1479-1482, 2013 | 783 | 2013 |
| Methotrexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon alfa-2b versus MAP alone in patients with resectable high-grade osteosarcoma and good … SS Bielack, S Smeland, JS Whelan, N Marina, G Jovic, JM Hook, ... Journal of Clinical Oncology 33 (20), 2279, 2015 | 390 | 2015 |
| Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency M Kovac, C Blattmann, S Ribi, J Smida, NS Mueller, F Engert, ... Nature communications 6 (1), 8940, 2015 | 309 | 2015 |
| Revised histopathological consensus classification of joint implant related pathology V Krenn, L Morawietz, G Perino, H Kienapfel, R Ascherl, GJ Hassenpflug, ... Pathology-Research and Practice 210 (12), 779-786, 2014 | 308 | 2014 |
| Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples D Baumhoer, L Tornillo, S Stadlmann, M Roncalli, EK Diamantis, ... American journal of clinical pathology 129 (6), 899-906, 2008 | 302 | 2008 |
| Recurrent PTPRB and PLCG1 mutations in angiosarcoma S Behjati, PS Tarpey, H Sheldon, I Martincorena, P Van Loo, G Gundem, ... Nature genetics 46 (4), 376-379, 2014 | 298 | 2014 |
| Sarcoma classification by DNA methylation profiling C Koelsche, D Schrimpf, D Stichel, M Sill, F Sahm, DE Reuss, M Blattner, ... Nature communications 12 (1), 498, 2021 | 288 | 2021 |
| Nasal chondrocyte-based engineered autologous cartilage tissue for repair of articular cartilage defects: an observational first-in-human trial M Mumme, A Barbero, S Miot, A Wixmerten, S Feliciano, F Wolf, ... The Lancet 388 (10055), 1985-1994, 2016 | 257 | 2016 |
| Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma S Behjati, PS Tarpey, K Haase, H Ye, MD Young, LB Alexandrov, ... Nature communications 8 (1), 15936, 2017 | 213 | 2017 |
| Two mitosis-specific antibodies, MPM-2 and phospho-histone H3 (Ser28), allow rapid and precise determination of mitotic activity C Tapia, H Kutzner, T Mentzel, S Savic, D Baumhoer, K Glatz The American journal of surgical pathology 30 (1), 83-89, 2006 | 182 | 2006 |
| Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2 P Guilhamon, M Eskandarpour, D Halai, GA Wilson, A Feber, ... Nature communications 4 (1), 2166, 2013 | 180 | 2013 |
| H3F3A (Histone 3.3) G34W immunohistochemistry: a reliable marker defining benign and malignant giant cell tumor of bone F Amary, F Berisha, H Ye, M Gupta, A Gutteridge, D Baumhoer, ... The American journal of surgical pathology 41 (8), 1059-1068, 2017 | 178 | 2017 |
| Mesenchymal chondrosarcoma: prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study AM Frezza, M Cesari, D Baumhoer, D Biau, S Bielack, DA Campanacci, ... European journal of cancer 51 (3), 374-381, 2015 | 161 | 2015 |
| Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast‐rich mimics N Presneau, D Baumhoer, S Behjati, N Pillay, P Tarpey, PJ Campbell, ... The Journal of Pathology: Clinical Research 1 (2), 113-123, 2015 | 158 | 2015 |
| Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions P Ruemmele, W Dietmaier, L Terracciano, L Tornillo, F Bataille, A Kaiser, ... The American journal of surgical pathology 33 (5), 691-704, 2009 | 150 | 2009 |
| The driver landscape of sporadic chordoma PS Tarpey, S Behjati, MD Young, I Martincorena, LB Alexandrov, ... Nature communications 8 (1), 890, 2017 | 129 | 2017 |
| Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma J Smida, D Baumhoer, M Rosemann, A Walch, S Bielack, C Poremba, ... Clinical Cancer Research 16 (16), 4256-4267, 2010 | 129 | 2010 |
| The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma MF Amary, F Berisha, R Mozela, R Gibbons, A Guttridge, P O'Donnell, ... Histopathology 69 (1), 121-127, 2016 | 118 | 2016 |
